View printer-friendly version << Back

LeMaitre Vascular to Present at the Canaccord Genuity Cardiovascular Conference


BURLINGTON, Mass., Dec 1, 2011 (GlobeNewswire via COMTEX) --

LeMaitre Vascular, Inc. (Nasdaq:LMAT), is presenting at the Canaccord Genuity 6th Annual Cardiovascular Conference at the St. Regis Hotel in San Francisco, CA. JJ Pellegrino, Chief Financial Officer, will provide an update on the company on Tuesday, December 6, 2011 at 11:20 am PST.

A live audio webcast of the presentation will be available via the Internet at and will be available for replay for approximately 30 days.

On December 8, 2011, LeMaitre Vascular will also participate in the 7th annual Lambert, Edwards & Associates SMID-West Investor Conference 2011 at The Palmer House Hilton Hotel in Chicago, IL. The company will be represented by Brian Kickham, Counsel & Business Development Associate.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. We sell vascular devices and implants to address the needs of our core customer, the vascular surgeon. Well-known to vascular surgeons, the Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart, including the Expandable LeMaitre Valvulotome and the Pruitt F3 Carotid Shunt. Our principal executive offices are located at 63 Second Avenue, Burlington, Massachusetts 01803. Additional information can be found at

The LeMaitre Vascular, Inc. logo is available at

This news release was distributed by GlobeNewswire,

SOURCE: LeMaitre Vascular, Inc.

CONTACT: LeMaitre Vascular, Inc.
Investor Relations
Brian Kickham